Switch to:
More From Other Websites
Mylan's EpiPen Price Increases Highlight Its Grip on the Market Aug 26 2016
Mylan Reacts to EpiPen Backlash Aug 25 2016
US Patent and Trademark Office Invalidates Two Copaxone 40 Patents Aug 25 2016
Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out Aug 25 2016
After Mylan uproar, a generic EpiPen could hit the market in 2017 Aug 25 2016
Why is there no generic EpiPen? Aug 25 2016
Teva Stock Gains, Leerink: Despite Patent Loss, No Generic Competition Until 2018 Aug 25 2016
Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16? Aug 25 2016
Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and... Aug 25 2016
Major Pharma Short Interest Faces Significant Drop Aug 25 2016
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone Aug 25 2016
Mylan wins round in fight with Teva over multiple sclerosis drug Aug 24 2016
Shares of Teva Pharmaceuticals fall after US Patent Office invalidates two patents Aug 24 2016
5:48 pm Teva Pharma confirms PTAB's decisions on two patents in IPR challenge to COPAXONE 40 mg;... Aug 24 2016
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg Aug 24 2016
What's next for Mylan? Aug 24 2016
Teva Stock Drops After Patent Invalidated Aug 24 2016
Teva drug patent invalidated by US regulator Aug 24 2016
Teva Plunges After Two U.S. Copaxone Patents Invalidated Aug 24 2016
Litigation Has Teva Pharmaceutical’s Copaxone 40 mg All Tied Up Aug 24 2016
Teva Pharm eyes more acquisitions after buying Allergan's generics business Aug 04 2016
Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA Aug 03 2016
Allergan to sell Anda drug distribution business to Teva Aug 03 2016
Teva completes $40 bn purchase of Allergan generics arm Aug 02 2016
Teva completes $40 bn purchase of Allergan generics arm Aug 02 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva expect to close $40.5B Allergan generic deal next week Jul 27 2016
Five high-grade issuers announce deals Jul 20 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd. Jun 16 2016
Mesoblast shares tank after Teva exit Jun 14 2016
Mesoblast shares drop on outlook concerns Jun 13 2016
Teva stops selling migraine patch after reports of burns Jun 13 2016
Dr. Reddy’s to acquire product portfolio from TEVA for US Market Jun 11 2016
Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan Jun 11 2016
Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan Jun 11 2016
Teva Announces New Collaboration with GRAMMY Nominated Artist Jhené Aiko Jun 01 2016
Allergan CEO says company is 'weeks away' from closing Teva deal May 23 2016
Takeda and Teva Establish "Teva Takeda Yakuhin Ltd." in Japan Mar 31 2016
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan Mar 31 2016
Teva Pharm sees close of $40.5 billion Allergan generics deal by June Mar 15 2016
EU approves Teva bid for Allergan's generics with conditions Mar 10 2016
Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources Mar 09 2016
Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources Mar 09 2016
Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources Mar 09 2016
Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources Mar 09 2016
Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources Mar 09 2016
Teva offers EU concessions over Allergan generics deal - EU Feb 19 2016
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine... Jan 28 2016
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine... Jan 28 2016
Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016 Jan 28 2016
Teva Releases Innovation and Social Responsibility Highlights Jan 25 2016
Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor Jan 07 2016
Teva to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
Teva Announces Launch of Generic Ortho Tri-Cyclen® Lo in the United States Jan 05 2016
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple... Jan 04 2016
Teva Announces Exercise of Underwriters’ Over-Allotment Option Jan 03 2016
CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with... Dec 27 2015
Teva divesting $1 billion in assets to clear Allergan deal - sources Dec 03 2015
Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for... Nov 25 2015
Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New... Nov 19 2015
Exclusive - Beyond Valeant, U.S. payers scrutinize other drugmaker ties to pharmacies Oct 30 2015
Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln Oct 01 2015
Teva to buy Mexico's Rimsa for $2.3 bln Oct 01 2015
Perrigo urges shareholders to reject Mylan takeover offer Sep 17 2015
Mylan opens $27.14 billion hostile bid for Perrigo Sep 15 2015
Mylan says it will launch $27.14B bid for Perrigo Sep 08 2015
Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
Chinese market dive pressures US stocks Jul 27 2015
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
Teva to lift bid for Mylan: report Jul 06 2015
Exclusive - Teva poised to raise its stake in Mylan -sources Jun 02 2015
Teva to pay $1.2 bn fine to settle US antitrust case May 28 2015
Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy Apr 29 2015
US STOCKS-Wall St reverses course to trade lower as health stocks drag Apr 27 2015
Generic drugmaker Mylan goes hostile in bid for Perrigo Apr 24 2015
Generic drugmaker Teva makes $40 billion offer for rival Mylan Apr 21 2015
Top Mylan shareholders seek deal with Teva - sources Apr 21 2015
Teva Pharmaceutical offers to buy Mylan for $40.1 bn Apr 21 2015
Teva formalises offer to acquire Mylan for $82 a share in cash and stock Apr 21 2015
US STOCKS-Wall St edges up as results ease anxiety over earnings Apr 21 2015
Teva Pharmaceutical offers to buy Mylan for $31 bn Apr 21 2015
Generic drugmaker Mylan offers $29 billion for Perrigo Apr 08 2015
US STOCKS-Wall St rebounds from recent losses; deals help Mar 30 2015
US STOCKS-Wall St higher as biotechs rally on M&A deals Mar 30 2015
U.S. Supreme Court rules for Teva over MS drug patent Jan 20 2015
Teva Pharm sees 2015 revenue lower than forecast Dec 11 2014
UK court backs Teva rival to AstraZeneca lung drug Sep 03 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK